GCM
WST icon

Gladstone Capital Management’s West Pharmaceutical WST Stock Holding History

Gladstone Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-891
Closed -$314K – 24
2023
Q4 		$314K Sell
891
-229,503
-100% -$81.2M 0.04% 14
2023
Q3 		$86.4M Buy
230,394
+222,394
+2,780% +$86M 8.83% 4
2023
Q2 		$3.06M Buy
+8,000
New +$2.86M 0.34% 13

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Gladstone Capital Management's WST Position: Q1 2024 in Review

Gladstone Capital Management sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 891 shares — an estimated $314K sold.

Gladstone Capital Management first reported a position in WST in Q2 2023 and held it in 3 quarters. The position peaked at $86.4M in Q3 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Gladstone Capital Management reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Gladstone Capital Management sold 891 West Pharmaceutical shares in Q1 2024, an estimated $314K.
  • Gladstone Capital Management first reported a position in West Pharmaceutical in Q2 2023 and held it in 3 quarters.
  • Gladstone Capital Management's West Pharmaceutical position peaked at $86.4M in Q3 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Gladstone Capital Management's 13F filing for Q1 2024, filed 15 May 2024.